Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDOPACT: Atazanavir vs Standard Protease Inhibitors on Endothelial Function in HIV
NCT00447070Phase 4Completed
- Sponsor
- Foundation for Cardiovascular Research
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atazanavir in human immunodeficiency virus infection (HIV), dyslipidemia, sponsored by Foundation for Cardiovascular Research. Started Aug 2004; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)dyslipidemia
Beyond the preview
Go deeper on NCT00447070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00447070.